首页> 外文期刊>International Journal of Molecular Sciences >Ruthenium(III) Complexes of Heterocyclic Tridentate (ONN) Schiff Base: Synthesis, Characterization and its Biological Properties as an Antiradical and Antiproliferative Agent
【24h】

Ruthenium(III) Complexes of Heterocyclic Tridentate (ONN) Schiff Base: Synthesis, Characterization and its Biological Properties as an Antiradical and Antiproliferative Agent

机译:杂环三齿(ONN)Schiff碱钌(III)配合物:合成,表征及其作为抗自由基和抗增殖剂的生物学性质

获取原文
           

摘要

The current work reports the synthesis, spectroscopic studies, antiradical and antiproliferative properties of four ruthenium(III) complexes of heterocyclic tridentate Schiff base bearing a simple 2′,4′-dihydroxyacetophenone functionality and ethylenediamine as the bridging ligand with RCHO moiety. The reaction of the tridentate ligands with RuCl 3 ·3H 2 O lead to the formation of neutral complexes of the type [Ru(L)Cl 2 (H 2 O)] (where L = tridentate NNO ligands). The compounds were characterized by elemental analysis, UV-vis, conductivity measurements, FTIR spectroscopy and confirmed the proposed octahedral geometry around the Ru ion. The Ru(III) compounds showed antiradical potentials against 2,2-Diphenyl-1-Picrylhydrazyl (DPPH) and 2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radicals, with DPPH scavenging capability in the order: [(PAEBOD)RuCl 2 ] > [(BZEBOD)RuCl 2 ] > [(MOABOD)RuCl 2 ] > [Vit. C] > [rutin] > [(METBOD)RuCl 2 ], and ABTS radical in the order: [(PAEBOD)RuCl 2 ] < [(MOABOD)RuCl 2 ] < [(BZEBOD)RuCl 2 ] < [(METBOD)RuCl 2 ]. Furthermore, in vitro anti-proliferative activity was investigated against three human cancer cell lines: renal cancer cell (TK-10), melanoma cancer cell (UACC-62) and breast cancer cell (MCF-7) by SRB assay.
机译:目前的工作报道了杂环三齿席夫碱的四个钌(III)配合物的合成,光谱研究,抗自由基和抗增殖性能,这些席夫碱具有简单的2',4'-二羟基苯乙酮官能团和乙二胺作为具有RCHO部分的桥联配体。三齿配体与RuCl 3·3H 2 O的反应导致形成[Ru(L)Cl 2(H 2 O)]类型的中性络合物(其中L =三齿NNO配体)。通过元素分析,紫外可见,电导率测量,FTIR光谱对化合物进行表征,并证实了Ru离子周围拟议的八面体几何形状。 Ru(III)化合物对2,2-二苯基-1-吡啶并肼基(DPPH)和2,2'-叠氮基双-(3-乙基苯并噻唑啉-6-磺酸)(ABTS)自由基具有抗自由基能力,在顺序:[(PAEBOD)RuCl 2]> [(BZEBOD)RuCl 2]> [(MOABOD)RuCl 2]> [Vit。 C]> [芦丁]> [(METBOD)RuCl 2],然后按以下顺序排列ABTS自由基:[(PAEBOD)RuCl 2] <[(MOABOD)RuCl 2] <[(BZEBOD)RuCl 2] <[(METBOD) RuCl 2]。此外,通过SRB分析研究了针对三种人类癌细胞系的体外抗增殖活性:肾癌细胞(TK-10),黑素瘤癌细胞(UACC-62)和乳腺癌细胞(MCF-7)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号